Cargando…

HIV Encephalopathy: pediatric case series description and insights from the clinic coalface

BACKGROUND: The Human Immune Deficiency Virus (HIV) can manifest neurologically in both adults and children. Early invasion of the central nervous system by the virus, affecting the developing brain, is believed to result in the most common primary HIV-related neurological complication, HIV Encephal...

Descripción completa

Detalles Bibliográficos
Autores principales: Donald, Kirsten A, Walker, Kathleen G, Kilborn, Tracy, Carrara, Henri, Langerak, Nelleke G, Eley, Brian, Wilmshurst, Jo M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297380/
https://www.ncbi.nlm.nih.gov/pubmed/25598835
http://dx.doi.org/10.1186/s12981-014-0042-7
_version_ 1782353137775935488
author Donald, Kirsten A
Walker, Kathleen G
Kilborn, Tracy
Carrara, Henri
Langerak, Nelleke G
Eley, Brian
Wilmshurst, Jo M
author_facet Donald, Kirsten A
Walker, Kathleen G
Kilborn, Tracy
Carrara, Henri
Langerak, Nelleke G
Eley, Brian
Wilmshurst, Jo M
author_sort Donald, Kirsten A
collection PubMed
description BACKGROUND: The Human Immune Deficiency Virus (HIV) can manifest neurologically in both adults and children. Early invasion of the central nervous system by the virus, affecting the developing brain, is believed to result in the most common primary HIV-related neurological complication, HIV Encephalopathy (HIVE). In countries such as South Africa where many children have not been initiated on antiretroviral treatment early, HIVE remains a significant clinical problem. METHODS: Children were selected from a clinic for children with neurologic complications of HIV, located at the Red Cross War Memorial Children’s Hospital, South Africa 2008–2012. Eligible subjects fulfilled the following inclusion criteria: aged 6 months-13 years; positive diagnosis of HIV infection, vertically infected and HIVE as defined by CDC criteria. Each participant was prospectively assessed by a Pediatric Neurologist using a standardized proforma which collated relevant details of background, clinical and immunological status. RESULTS: The median age of the 87 children was 64 months (interquartile range 27–95 months). All except one child were on antiretroviral treatment, 45% had commenced treatment <12 months of age. Delayed early motor milestones were reported in 80% and delayed early speech in 75% of children in whom we had the information. Twenty percent had a history of one or more seizures and 41% had a history of behavior problems. Forty-eight percent had microcephaly and 63% a spastic diplegia. CD4 percentages followed a normal distribution with mean of 30.3% (SD 8.69). Viral loads were undetectable (<log 1.6) in 70% of the children. Brain imaging was performed on 56% with 71% of those imaged demonstrating at least one abnormality, most commonly white matter volume loss or signal abnormality. CONCLUSIONS: Amongst the cohort of children referred to this clinic, the diagnosis of HIVE was unrecognized in the general medical services, even in its most severe form. Developmental delay and school failure were major presenting problems. Co-morbidities are a frequent finding and should be sought actively in order to optimize management and promote best possible outcomes for this vulnerable group of children.
format Online
Article
Text
id pubmed-4297380
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42973802015-01-18 HIV Encephalopathy: pediatric case series description and insights from the clinic coalface Donald, Kirsten A Walker, Kathleen G Kilborn, Tracy Carrara, Henri Langerak, Nelleke G Eley, Brian Wilmshurst, Jo M AIDS Res Ther Research BACKGROUND: The Human Immune Deficiency Virus (HIV) can manifest neurologically in both adults and children. Early invasion of the central nervous system by the virus, affecting the developing brain, is believed to result in the most common primary HIV-related neurological complication, HIV Encephalopathy (HIVE). In countries such as South Africa where many children have not been initiated on antiretroviral treatment early, HIVE remains a significant clinical problem. METHODS: Children were selected from a clinic for children with neurologic complications of HIV, located at the Red Cross War Memorial Children’s Hospital, South Africa 2008–2012. Eligible subjects fulfilled the following inclusion criteria: aged 6 months-13 years; positive diagnosis of HIV infection, vertically infected and HIVE as defined by CDC criteria. Each participant was prospectively assessed by a Pediatric Neurologist using a standardized proforma which collated relevant details of background, clinical and immunological status. RESULTS: The median age of the 87 children was 64 months (interquartile range 27–95 months). All except one child were on antiretroviral treatment, 45% had commenced treatment <12 months of age. Delayed early motor milestones were reported in 80% and delayed early speech in 75% of children in whom we had the information. Twenty percent had a history of one or more seizures and 41% had a history of behavior problems. Forty-eight percent had microcephaly and 63% a spastic diplegia. CD4 percentages followed a normal distribution with mean of 30.3% (SD 8.69). Viral loads were undetectable (<log 1.6) in 70% of the children. Brain imaging was performed on 56% with 71% of those imaged demonstrating at least one abnormality, most commonly white matter volume loss or signal abnormality. CONCLUSIONS: Amongst the cohort of children referred to this clinic, the diagnosis of HIVE was unrecognized in the general medical services, even in its most severe form. Developmental delay and school failure were major presenting problems. Co-morbidities are a frequent finding and should be sought actively in order to optimize management and promote best possible outcomes for this vulnerable group of children. BioMed Central 2015-01-17 /pmc/articles/PMC4297380/ /pubmed/25598835 http://dx.doi.org/10.1186/s12981-014-0042-7 Text en © Donald et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Donald, Kirsten A
Walker, Kathleen G
Kilborn, Tracy
Carrara, Henri
Langerak, Nelleke G
Eley, Brian
Wilmshurst, Jo M
HIV Encephalopathy: pediatric case series description and insights from the clinic coalface
title HIV Encephalopathy: pediatric case series description and insights from the clinic coalface
title_full HIV Encephalopathy: pediatric case series description and insights from the clinic coalface
title_fullStr HIV Encephalopathy: pediatric case series description and insights from the clinic coalface
title_full_unstemmed HIV Encephalopathy: pediatric case series description and insights from the clinic coalface
title_short HIV Encephalopathy: pediatric case series description and insights from the clinic coalface
title_sort hiv encephalopathy: pediatric case series description and insights from the clinic coalface
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297380/
https://www.ncbi.nlm.nih.gov/pubmed/25598835
http://dx.doi.org/10.1186/s12981-014-0042-7
work_keys_str_mv AT donaldkirstena hivencephalopathypediatriccaseseriesdescriptionandinsightsfromthecliniccoalface
AT walkerkathleeng hivencephalopathypediatriccaseseriesdescriptionandinsightsfromthecliniccoalface
AT kilborntracy hivencephalopathypediatriccaseseriesdescriptionandinsightsfromthecliniccoalface
AT carrarahenri hivencephalopathypediatriccaseseriesdescriptionandinsightsfromthecliniccoalface
AT langeraknellekeg hivencephalopathypediatriccaseseriesdescriptionandinsightsfromthecliniccoalface
AT eleybrian hivencephalopathypediatriccaseseriesdescriptionandinsightsfromthecliniccoalface
AT wilmshurstjom hivencephalopathypediatriccaseseriesdescriptionandinsightsfromthecliniccoalface